The efficacy of the probiotics for gestational diabetes patients

The efficacy of the probiotics for gestational diabetes patients - The efficacy of the probiotics for gestational diabetes patients

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000012416

Enrollment

Registered

2013-12-01

Start date

2012-08-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

gestational diabetes mellitus

Interventions

Patients should take 1 yogult(Onakani GG, Takanashi) under standard diet therapy. standard diet therapy

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: patients who diagnosed GDM

Exclusion criteria

Exclusion criteria: patients who are allergic to probiotics patients who have CKD, severe liver failure,severe infection patients who are under steroidal therapy patients who were suffered from severe ketosis in recent six months

Design outcomes

Primary

Measure	Time frame
The rate of insulin therapy for GDM patients, baby's body weight, the number of the patients after labor who diagnosed prediabetes status or diabetes.	—

Countries

Japan

Contacts

Public ContactMegumi Gonai

Kantoh Rosai Hospital department of diabetes and endocrinology

teamdm@kantoh.rofuku.go.jp044-411-3131

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026